CDH1 and breast cancer: This finding is in concordance with most previous studies (Lipponen et al, 1994; Siitonen et al, 1996), and strengthens the hypothesis of E-cadherin being a metastasis-suppressing molecule and a prognostic indicator in breast cancer.